The fight against COVID-19 has entered a new phase in 2024, one in which vaccinations have become “routine”, like an annual flu shot.
Currently browsing: General
ASSURE In the News
Rapid Testing and Stemming COVID-19 Spread During the Winter of 2024
As we enter the winter of 2024, concerns over COVID-19 transmission are heightened due to increased indoor activities, increased travel and holiday-related gatherings, and prevalence of other seasonal respiratory illnesses.
New Study Finds 100% Correlation Between Rapid Antigen Test Results and Culturable Virus Levels
Researchers have been studying the question of whether rapid antigen tests are a good indicator of contagiousness, or infectiousness, when it comes to the SARS-CoV-2 virus.
Despite Vaccines, the Need for Rapid COVID-19 Tests Remains
The need for rapid COVID-19 tests will certainly continue throughout 2021, despite the great progress made on vaccines. Shots will reach everyone who wants them, sooner or later, but perhaps not as quickly as we may like. Rapid tests could be made available right now, without a prescription, so we don’t have to wait months for the vaccine to arrive.
COVID-19 Cases Still Growing, Links to Academic Papers
On October 24th, the United States tracked 78,702 new infections of Covid-19, a +32% 14-day change. The same day, 871 new COVID-related deaths were counted, this represents a +15% 14-day change. Click to find links to important academic papers from experts at Harvard, the University of Colorado at Boulder, Yale University, and more.
PRESS RELEASE | ASSURE-19 Begins Clinical Testing to Acquire FDA Emergency Use Authorization
Oceanit and the Queen’s Medical Center have started patient trials with ASSURE-19 rapid point-of-need covid-19 tests as of Saturday, August 22. Oceanit is collaborating with Dr. Todd B. Seto, QMC’s director of academic affairs and research, to obtain critical test data. This is the beginning of the journey to acquire US Food and Drug Administration Emergency Use Authorization (EUA).